Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Human Prothrombin Complex Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Global Human Prothrombin Complex Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Industry: Pharma & Healthcare
Published Date: 2024-04-17
Pages: 142 Pages
Report ld: 2695916
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Human Prothrombin Complex Market Size(US$)
CAGR 2024-2030
11.8%
Market Size,2030
USD 3,473.8
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 1,778.9 million
Market Forecast in 2030(Value)
US$ 3,473.8 million
CAGR
11.8%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
The global Human Prothrombin Complex market size was US$ 1577 million in 2023 and is forecast to a readjusted size of US$ 3473.8 million by 2030 with a CAGR of 11.8% during the forecast period 2024-2030.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
In terms of sales (consumption) side, this report focuses on the sales of Human Prothrombin Complex by regions (Countries), company, by type and by type. from 2019 to 2024 and forecast to 2030.
The global Human Prothrombin Complex market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Human Prothrombin Complex market. These figures have been provided in terms of both revenue and sales for the period 2019-2030. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.
MARKET SEGMENTATION
By Company
- Takeda
- CSL
- Grifols
- Octapharma
- Hualan Biological
- Meheco Xinxing Pharma
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- 500 IU/Vial
- 600 IU/Vial
- 1000 IU/Vial
- Others
Segment by Application
- Hemophilia B
- Vitamin K Deficiency
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Human Prothrombin Complex in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7: Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8: China by company, by type and by application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Prothrombin Complex sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Human Prothrombin Complex Definition
1.2 Market by Type
1.2.1 Global Human Prothrombin Complex Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 500 IU/Vial
1.2.3 600 IU/Vial
1.2.4 1000 IU/Vial
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global Human Prothrombin Complex Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hemophilia B
1.3.3 Vitamin K Deficiency
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Human Prothrombin Complex Sales
2.1 Global Human Prothrombin Complex Revenue Estimates and Forecasts 2019-2030
2.2 Global Human Prothrombin Complex Revenue by Region: 2019 VS 2023 VS 2030
2.3 Global Human Prothrombin Complex Revenue by Region
2.3.1 Global Human Prothrombin Complex Revenue by Region (2019-2024)
2.3.2 Global Human Prothrombin Complex Revenue by Region (2025-2030)
2.4 Global Human Prothrombin Complex Sales Quantity Estimates and Forecasts 2019-2030
2.5 Global Human Prothrombin Complex Sales Quantity by Region: 2019 VS 2023 VS 2030
2.6 Global Human Prothrombin Complex Sales Quantity by Region
2.6.1 Global Human Prothrombin Complex Sales Quantity by Region (2019-2024)
2.6.2 Global Human Prothrombin Complex Sales Quantity by Region (2025-2030)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Human Prothrombin Complex Sales Quantity by Manufacturers
3.1.1 Global Human Prothrombin Complex Sales Quantity by Manufacturers (2019-2024)
3.1.2 Global Human Prothrombin Complex Sales Quantity Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Companies by Human Prothrombin Complex Sales in 2023
3.2 Global Human Prothrombin Complex Revenue by Manufacturers
3.2.1 Global Human Prothrombin Complex Revenue by Manufacturers (2019-2024)
3.2.2 Global Human Prothrombin Complex Revenue Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Human Prothrombin Complex Revenue in 2023
3.3 Global Human Prothrombin Complex Sales Price by Manufacturers
3.4 Global Key Players of Human Prothrombin Complex, Industry Ranking, 2022 VS 2023
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Human Prothrombin Complex, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Human Prothrombin Complex, Product Offered and Application
3.8 Global Key Manufacturers of Human Prothrombin Complex, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Human Prothrombin Complex Sales Quantity by Type
4.1.1 Global Human Prothrombin Complex Historical Sales Quantity by Type (2019-2024)
4.1.2 Global Human Prothrombin Complex Forecasted Sales Quantity by Type (2025-2030)
4.1.3 Global Human Prothrombin Complex Sales Quantity Market Share by Type (2019-2030)
4.2 Global Human Prothrombin Complex Revenue by Type
4.2.1 Global Human Prothrombin Complex Historical Revenue by Type (2019-2024)
4.2.2 Global Human Prothrombin Complex Forecasted Revenue by Type (2025-2030)
4.2.3 Global Human Prothrombin Complex Revenue Market Share by Type (2019-2030)
4.3 Global Human Prothrombin Complex Price by Type
4.3.1 Global Human Prothrombin Complex Price by Type (2019-2024)
4.3.2 Global Human Prothrombin Complex Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Human Prothrombin Complex Sales Quantity by Application
5.1.1 Global Human Prothrombin Complex Historical Sales Quantity by Application (2019-2024)
5.1.2 Global Human Prothrombin Complex Forecasted Sales Quantity by Application (2025-2030)
5.1.3 Global Human Prothrombin Complex Sales Quantity Market Share by Application (2019-2030)
5.2 Global Human Prothrombin Complex Revenue by Application
5.2.1 Global Human Prothrombin Complex Historical Revenue by Application (2019-2024)
5.2.2 Global Human Prothrombin Complex Forecasted Revenue by Application (2025-2030)
5.2.3 Global Human Prothrombin Complex Revenue Market Share by Application (2019-2030)
5.3 Global Human Prothrombin Complex Price by Application
5.3.1 Global Human Prothrombin Complex Price by Application (2019-2024)
5.3.2 Global Human Prothrombin Complex Price Forecast by Application (2025-2030)
6 North America
6.1 North America Human Prothrombin Complex Sales by Company
6.1.1 North America Human Prothrombin Complex Revenue by Company (2019-2024)
6.1.2 North America Human Prothrombin Complex Sales Quantity by Company (2019-2024)
6.2 North America Human Prothrombin Complex Market Size by Type
6.2.1 North America Human Prothrombin Complex Sales Quantity by Type (2019-2030)
6.2.2 North America Human Prothrombin Complex Revenue by Type (2019-2030)
6.3 North America Human Prothrombin Complex Market Size by Application
6.3.1 North America Human Prothrombin Complex Sales Quantity by Application (2019-2030)
6.3.2 North America Human Prothrombin Complex Revenue by Application (2019-2030)
6.4 North America Human Prothrombin Complex Market Size by Country
6.4.1 North America Human Prothrombin Complex Revenue by Country: 2019 VS 2023 VS 2030
6.4.2 North America Human Prothrombin Complex Revenue by Country (2019-2030)
6.4.3 North America Human Prothrombin Complex Sales Quantity by Country (2019-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Human Prothrombin Complex Sales by Company
7.1.1 Europe Human Prothrombin Complex Sales Quantity by Company (2019-2024)
7.1.2 Europe Human Prothrombin Complex Revenue by Company (2019-2024)
7.2 Europe Human Prothrombin Complex Market Size by Type
7.2.1 Europe Human Prothrombin Complex Sales Quantity by Type (2019-2030)
7.2.2 Europe Human Prothrombin Complex Revenue by Type (2019-2030)
7.3 Europe Human Prothrombin Complex Market Size by Application
7.3.1 Europe Human Prothrombin Complex Sales Quantity by Application (2019-2030)
7.3.2 Europe Human Prothrombin Complex Revenue by Application (2019-2030)
7.4 Europe Human Prothrombin Complex Market Size by Country
7.4.1 Europe Human Prothrombin Complex Revenue by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Human Prothrombin Complex Revenue by Country (2019-2030)
7.4.3 Europe Human Prothrombin Complex Sales Quantity by Country (2019-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Human Prothrombin Complex Sales by Company
8.1.1 China Human Prothrombin Complex Sales Quantity by Company (2019-2024)
8.1.2 China Human Prothrombin Complex Revenue by Company (2019-2024)
8.2 China Human Prothrombin Complex Market Size by Type
8.2.1 China Human Prothrombin Complex Sales Quantity by Type (2019-2030)
8.2.2 China Human Prothrombin Complex Revenue by Type (2019-2030)
8.3 China Human Prothrombin Complex Market Size by Application
8.3.1 China Human Prothrombin Complex Sales Quantity by Application (2019-2030)
8.3.2 China Human Prothrombin Complex Revenue by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Human Prothrombin Complex Sales by Company
9.1.1 APAC Human Prothrombin Complex Sales Quantity by Company (2019-2024)
9.1.2 APAC Human Prothrombin Complex Revenue by Company (2019-2024)
9.2 APAC Human Prothrombin Complex Market Size by Type
9.2.1 APAC Human Prothrombin Complex Sales Quantity by Type (2019-2030)
9.2.2 APAC Human Prothrombin Complex Revenue by Type (2019-2030)
9.3 APAC Human Prothrombin Complex Market Size by Application
9.3.1 APAC Human Prothrombin Complex Sales Quantity by Application (2019-2030)
9.3.2 APAC Human Prothrombin Complex Revenue by Application (2019-2030)
9.4 APAC Human Prothrombin Complex Market Size by Region
9.4.1 APAC Human Prothrombin Complex Revenue by Region: 2019 VS 2023 VS 2030
9.4.2 APAC Human Prothrombin Complex Revenue by Region (2019-2030)
9.4.3 APAC Human Prothrombin Complex Sales Quantity by Region (2019-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Human Prothrombin Complex Sales by Company
10.1.1 Middle East, Africa and Latin America Human Prothrombin Complex Sales Quantity by Company (2019-2024)
10.1.2 Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Company (2019-2024)
10.2 Middle East, Africa and Latin America Human Prothrombin Complex Market Size by Type
10.2.1 Middle East, Africa and Latin America Human Prothrombin Complex Sales Quantity by Type (2019-2030)
10.2.2 Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Type (2019-2030)
10.3 Middle East, Africa and Latin America Human Prothrombin Complex Market Size by Application
10.3.1 Middle East, Africa and Latin America Human Prothrombin Complex Sales Quantity by Application (2019-2030)
10.3.2 Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Application (2019-2030)
10.4 Middle East, Africa and Latin America Human Prothrombin Complex Market Size by Country
10.4.1 Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Country (2019-2030)
10.4.3 Middle East, Africa and Latin America Human Prothrombin Complex Sales Quantity by Country (2019-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Overview
11.1.3 Takeda Human Prothrombin Complex Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.1.4 Takeda Human Prothrombin Complex Products and Services
11.1.5 Takeda Human Prothrombin Complex SWOT Analysis
11.1.6 Takeda Recent Developments
11.2 CSL
11.2.1 CSL Company Information
11.2.2 CSL Overview
11.2.3 CSL Human Prothrombin Complex Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.2.4 CSL Human Prothrombin Complex Products and Services
11.2.5 CSL Human Prothrombin Complex SWOT Analysis
11.2.6 CSL Recent Developments
11.3 Grifols
11.3.1 Grifols Company Information
11.3.2 Grifols Overview
11.3.3 Grifols Human Prothrombin Complex Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.3.4 Grifols Human Prothrombin Complex Products and Services
11.3.5 Grifols Human Prothrombin Complex SWOT Analysis
11.3.6 Grifols Recent Developments
11.4 Octapharma
11.4.1 Octapharma Company Information
11.4.2 Octapharma Overview
11.4.3 Octapharma Human Prothrombin Complex Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.4.4 Octapharma Human Prothrombin Complex Products and Services
11.4.5 Octapharma Human Prothrombin Complex SWOT Analysis
11.4.6 Octapharma Recent Developments
11.5 Hualan Biological
11.5.1 Hualan Biological Company Information
11.5.2 Hualan Biological Overview
11.5.3 Hualan Biological Human Prothrombin Complex Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.5.4 Hualan Biological Human Prothrombin Complex Products and Services
11.5.5 Hualan Biological Human Prothrombin Complex SWOT Analysis
11.5.6 Hualan Biological Recent Developments
11.6 Meheco Xinxing Pharma
11.6.1 Meheco Xinxing Pharma Company Information
11.6.2 Meheco Xinxing Pharma Overview
11.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Products and Services
11.6.5 Meheco Xinxing Pharma Human Prothrombin Complex SWOT Analysis
11.6.6 Meheco Xinxing Pharma Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Human Prothrombin Complex Value Chain Analysis
12.2 Human Prothrombin Complex Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Prothrombin Complex Production Mode & Process
12.4 Human Prothrombin Complex Sales and Marketing
12.4.1 Human Prothrombin Complex Sales Channels
12.4.2 Human Prothrombin Complex Distributors
12.5 Human Prothrombin Complex Customers
13 Market Dynamics
13.1 Human Prothrombin Complex Industry Trends
13.2 Human Prothrombin Complex Market Drivers
13.3 Human Prothrombin Complex Market Challenges
13.4 Human Prothrombin Complex Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Human Prothrombin Complex Market Size Growth Rate (CAGR) by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of 500 IU/Vial
Table 3. Major Manufacturers of 600 IU/Vial
Table 4. Major Manufacturers of 1000 IU/Vial
Table 5. Major Manufacturers of Others
Table 6. Global Human Prothrombin Complex Market Size Growth Rate (CAGR) by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Human Prothrombin Complex Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Human Prothrombin Complex Revenue by Region (2019-2024) & (US$ Million)
Table 9. Global Human Prothrombin Complex Revenue Market Share by Region (2019-2024)
Table 10. Global Human Prothrombin Complex Revenue by Region (2025-2030) & (US$ Million)
Table 11. Global Human Prothrombin Complex Revenue Market Share by Region (2025-2030)
Table 12. Global Human Prothrombin Complex Sales Quantity by Region: 2019 VS 2023 VS 2030 (K Units)
Table 13. Global Human Prothrombin Complex Sales by Region (2019-2024) & (K Units)
Table 14. Global Human Prothrombin Complex Sales Market Share by Region (2019-2024)
Table 15. Global Human Prothrombin Complex Sales by Region (2025-2030) & (K Units)
Table 16. Global Human Prothrombin Complex Sales Market Share by Region (2025-2030)
Table 17. Global Human Prothrombin Complex Sales Quantity by Manufacturers (2019-2024) & (K Units)
Table 18. Global Human Prothrombin Complex Sales Quantity Share by Manufacturers (2019-2024)
Table 19. Global Human Prothrombin Complex Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 20. Global Human Prothrombin Complex Revenue Share by Manufacturers (2019-2024)
Table 21. Global Human Prothrombin Complex Price by Manufacturers 2019-2024 (M USD/Unit)
Table 22. Global Key Players of Human Prothrombin Complex, Industry Ranking, 2022 VS 2023
Table 23. Global Human Prothrombin Complex Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Human Prothrombin Complex by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Prothrombin Complex as of 2023)
Table 25. Global Key Manufacturers of Human Prothrombin Complex, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Human Prothrombin Complex, Product Offered and Application
Table 27. Global Key Manufacturers of Human Prothrombin Complex, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Human Prothrombin Complex Sales Quantity by Type (2019-2024) & (K Units)
Table 30. Global Human Prothrombin Complex Sales Quantity by Type (2025-2030) & (K Units)
Table 31. Global Human Prothrombin Complex Sales Quantity Share by Type (2019-2024)
Table 32. Global Human Prothrombin Complex Sales Quantity Share by Type (2025-2030)
Table 33. Global Human Prothrombin Complex Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Human Prothrombin Complex Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Human Prothrombin Complex Revenue Share by Type (2019-2024)
Table 36. Global Human Prothrombin Complex Revenue Share by Type (2025-2030)
Table 37. Human Prothrombin Complex Price by Type (2019-2024) & (M USD/Unit)
Table 38. Global Human Prothrombin Complex Price Forecast by Type (2025-2030) & (M USD/Unit)
Table 39. Global Human Prothrombin Complex Sales Quantity by Application (2019-2024) & (K Units)
Table 40. Global Human Prothrombin Complex Sales Quantity by Application (2025-2030) & (K Units)
Table 41. Global Human Prothrombin Complex Sales Quantity Share by Application (2019-2024)
Table 42. Global Human Prothrombin Complex Sales Quantity Share by Application (2025-2030)
Table 43. Global Human Prothrombin Complex Revenue by Application (2019-2024) & (US$ Million)
Table 44. Global Human Prothrombin Complex Revenue by Application (2025-2030) & (US$ Million)
Table 45. Global Human Prothrombin Complex Revenue Share by Application (2019-2024)
Table 46. Global Human Prothrombin Complex Revenue Share by Application (2025-2030)
Table 47. Human Prothrombin Complex Price by Application (2019-2024) & (M USD/Unit)
Table 48. Global Human Prothrombin Complex Price Forecast by Application (2025-2030) & (M USD/Unit)
Table 49. North America Human Prothrombin Complex Revenue by Company (2019-2024) & (US$ Million)
Table 50. North America Human Prothrombin Complex Sales Quantity by Company (2019-2024) & (K Units)
Table 51. North America Human Prothrombin Complex Sales Quantity by Type (2019-2024) & (K Units)
Table 52. North America Human Prothrombin Complex Sales Quantity by Type (2025-2030) & (K Units)
Table 53. North America Human Prothrombin Complex Revenue by Type (2019-2024) & (US$ Million)
Table 54. North America Human Prothrombin Complex Revenue by Type (2025-2030) & (US$ Million)
Table 55. North America Human Prothrombin Complex Sales Quantity by Application (2019-2024) & (K Units)
Table 56. North America Human Prothrombin Complex Sales Quantity by Application (2025-2030) & (K Units)
Table 57. North America Human Prothrombin Complex Revenue by Application (2019-2024) & (US$ Million)
Table 58. North America Human Prothrombin Complex Revenue by Application (2025-2030) & (US$ Million)
Table 59. North America Human Prothrombin Complex Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 60. North America Human Prothrombin Complex Revenue by Country (2019-2024) & (US$ Million)
Table 61. North America Human Prothrombin Complex Revenue by Country (2025-2030) & (US$ Million)
Table 62. North America Human Prothrombin Complex Sales Quantity by Country (2019-2024) & (K Units)
Table 63. North America Human Prothrombin Complex Sales Quantity by Country (2025-2030) & (K Units)
Table 64. Europe Human Prothrombin Complex Sales Quantity by Company (2019-2024) & (K Units)
Table 65. Europe Human Prothrombin Complex Revenue by Company (2019-2024) & (US$ Million)
Table 66. Europe Human Prothrombin Complex Sales Quantity by Type (2019-2024) & (K Units)
Table 67. Europe Human Prothrombin Complex Sales Quantity by Type (2025-2030) & (K Units)
Table 68. Europe Human Prothrombin Complex Revenue by Type (2019-2024) & (US$ Million)
Table 69. Europe Human Prothrombin Complex Revenue by Type (2025-2030) & (US$ Million)
Table 70. Europe Human Prothrombin Complex Sales Quantity by Application (2019-2024) & (K Units)
Table 71. Europe Human Prothrombin Complex Sales Quantity by Application (2025-2030) & (K Units)
Table 72. Europe Human Prothrombin Complex Revenue by Application (2019-2024) & (US$ Million)
Table 73. Europe Human Prothrombin Complex Revenue by Application (2025-2030) & (US$ Million)
Table 74. Europe Human Prothrombin Complex Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 75. Europe Human Prothrombin Complex Revenue by Country (2019-2024) & (US$ Million)
Table 76. Europe Human Prothrombin Complex Revenue by Country (2025-2030) & (US$ Million)
Table 77. Europe Human Prothrombin Complex Sales Quantity by Country (2019-2024) & (K Units)
Table 78. Europe Human Prothrombin Complex Sales Quantity by Country (2025-2030) & (K Units)
Table 79. China Human Prothrombin Complex Sales Quantity by Company (2019-2024) & (K Units)
Table 80. China Human Prothrombin Complex Revenue by Company (2019-2024) & (US$ Million)
Table 81. China Human Prothrombin Complex Sales Quantity by Type (2019-2024) & (K Units)
Table 82. China Human Prothrombin Complex Sales Quantity by Type (2025-2030) & (K Units)
Table 83. China Human Prothrombin Complex Revenue by Type (2019-2024) & (US$ Million)
Table 84. China Human Prothrombin Complex Revenue by Type (2025-2030) & (US$ Million)
Table 85. China Human Prothrombin Complex Sales Quantity by Application (2019-2024) & (K Units)
Table 86. China Human Prothrombin Complex Sales Quantity by Application (2025-2030) & (K Units)
Table 87. China Human Prothrombin Complex Revenue by Application (2019-2024) & (US$ Million)
Table 88. China Human Prothrombin Complex Revenue by Application (2025-2030) & (US$ Million)
Table 89. APAC Human Prothrombin Complex Sales Quantity by Company (2019-2024) & (K Units)
Table 90. APAC Human Prothrombin Complex Revenue by Company (2019-2024) & (US$ Million)
Table 91. APAC Human Prothrombin Complex Sales Quantity by Type (2019-2024) & (K Units)
Table 92. APAC Human Prothrombin Complex Sales Quantity by Type (2025-2030) & (K Units)
Table 93. APAC Human Prothrombin Complex Revenue by Type (2019-2024) & (US$ Million)
Table 94. APAC Human Prothrombin Complex Revenue by Type (2025-2030) & (US$ Million)
Table 95. APAC Human Prothrombin Complex Sales Quantity by Application (2019-2024) & (K Units)
Table 96. APAC Human Prothrombin Complex Sales Quantity by Application (2025-2030) & (K Units)
Table 97. APAC Human Prothrombin Complex Revenue by Application (2019-2024) & (US$ Million)
Table 98. APAC Human Prothrombin Complex Revenue by Application (2025-2030) & (US$ Million)
Table 99. APAC Human Prothrombin Complex Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 100. APAC Human Prothrombin Complex Revenue by Region (2019-2024) & (US$ Million)
Table 101. APAC Human Prothrombin Complex Revenue by Region (2025-2030) & (US$ Million)
Table 102. APAC Human Prothrombin Complex Sales Quantity by Region (2019-2024) & (K Units)
Table 103. APAC Human Prothrombin Complex Sales Quantity by Region (2025-2030) & (K Units)
Table 104. Middle East, Africa and Latin America Human Prothrombin Complex Sales Quantity by Company (2019-2024) & (K Units)
Table 105. Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Company (2019-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Human Prothrombin Complex Sales Quantity by Type (2019-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Human Prothrombin Complex Sales Quantity by Type (2025-2030) & (K Units)
Table 108. Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Type (2019-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Type (2025-2030) & (US$ Million)
Table 110. Middle East, Africa and Latin America Human Prothrombin Complex Sales Quantity by Application (2019-2024) & (K Units)
Table 111. Middle East, Africa and Latin America Human Prothrombin Complex Sales Quantity by Application (2025-2030) & (K Units)
Table 112. Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Application (2019-2024) & (US$ Million)
Table 113. Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Application (2025-2030) & (US$ Million)
Table 114. Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 115. Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Country (2019-2024) & (US$ Million)
Table 116. Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Country (2025-2030) & (US$ Million)
Table 117. Middle East, Africa and Latin America Human Prothrombin Complex Sales Quantity by Country (2019-2024) & (K Units)
Table 118. Middle East, Africa and Latin America Human Prothrombin Complex Sales Quantity by Country (2025-2030) & (K Units)
Table 119. Takeda Company Information
Table 120. Takeda Description and Overview
Table 121. Takeda Human Prothrombin Complex Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (M USD/Unit) and Gross Margin (2019-2024)
Table 122. Takeda Human Prothrombin Complex Product and Services
Table 123. Takeda Human Prothrombin Complex SWOT Analysis
Table 124. Takeda Recent Developments
Table 125. CSL Company Information
Table 126. CSL Description and Overview
Table 127. CSL Human Prothrombin Complex Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (M USD/Unit) and Gross Margin (2019-2024)
Table 128. CSL Human Prothrombin Complex Product and Services
Table 129. CSL Human Prothrombin Complex SWOT Analysis
Table 130. CSL Recent Developments
Table 131. Grifols Company Information
Table 132. Grifols Description and Overview
Table 133. Grifols Human Prothrombin Complex Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (M USD/Unit) and Gross Margin (2019-2024)
Table 134. Grifols Human Prothrombin Complex Product and Services
Table 135. Grifols Human Prothrombin Complex SWOT Analysis
Table 136. Grifols Recent Developments
Table 137. Octapharma Company Information
Table 138. Octapharma Description and Overview
Table 139. Octapharma Human Prothrombin Complex Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (M USD/Unit) and Gross Margin (2019-2024)
Table 140. Octapharma Human Prothrombin Complex Product and Services
Table 141. Octapharma Human Prothrombin Complex SWOT Analysis
Table 142. Octapharma Recent Developments
Table 143. Hualan Biological Company Information
Table 144. Hualan Biological Description and Overview
Table 145. Hualan Biological Human Prothrombin Complex Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (M USD/Unit) and Gross Margin (2019-2024)
Table 146. Hualan Biological Human Prothrombin Complex Product and Services
Table 147. Hualan Biological Human Prothrombin Complex SWOT Analysis
Table 148. Hualan Biological Recent Developments
Table 149. Meheco Xinxing Pharma Company Information
Table 150. Meheco Xinxing Pharma Description and Overview
Table 151. Meheco Xinxing Pharma Human Prothrombin Complex Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (M USD/Unit) and Gross Margin (2019-2024)
Table 152. Meheco Xinxing Pharma Human Prothrombin Complex Product and Services
Table 153. Meheco Xinxing Pharma Human Prothrombin Complex SWOT Analysis
Table 154. Meheco Xinxing Pharma Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Human Prothrombin Complex Distributors List
Table 158. Human Prothrombin Complex Customers List
Table 159. Human Prothrombin Complex Market Trends
Table 160. Human Prothrombin Complex Market Drivers
Table 161. Human Prothrombin Complex Market Challenges
Table 162. Human Prothrombin Complex Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Prothrombin Complex Product Picture
Figure 2. Global Human Prothrombin Complex Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Human Prothrombin Complex Market Share by Type in 2023 & 2030
Figure 4. 500 IU/Vial Product Picture
Figure 5. 600 IU/Vial Product Picture
Figure 6. 1000 IU/Vial Product Picture
Figure 7. Others Product Picture
Figure 8. Global Human Prothrombin Complex Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 9. Global Human Prothrombin Complex Market Share by Application in 2023 & 2030
Figure 10. Hemophilia B
Figure 11. Vitamin K Deficiency
Figure 12. Others
Figure 13. Human Prothrombin Complex Report Years Considered
Figure 14. Global Human Prothrombin Complex Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Human Prothrombin Complex Revenue 2019-2030 (US$ Million)
Figure 16. Global Human Prothrombin Complex Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 17. Global Human Prothrombin Complex Sales Quantity 2019-2030 (K Units)
Figure 18. Global Human Prothrombin Complex Sales Quantity Market Share by Region (2019-2024)
Figure 19. Global Human Prothrombin Complex Sales Quantity Market Share by Region (2025-2030)
Figure 20. North America Human Prothrombin Complex Sales Quantity YoY (2019-2030) & (K Units)
Figure 21. North America Human Prothrombin Complex Revenue YoY (2019-2030) & (US$ Million)
Figure 22. Europe Human Prothrombin Complex Sales Quantity YoY (2019-2030) & (K Units)
Figure 23. Europe Human Prothrombin Complex Revenue YoY (2019-2030) & (US$ Million)
Figure 24. China Human Prothrombin Complex Sales Quantity YoY (2019-2030) & (K Units)
Figure 25. China Human Prothrombin Complex Revenue YoY (2019-2030) & (US$ Million)
Figure 26. APAC Human Prothrombin Complex Sales Quantity YoY (2019-2030) & (K Units)
Figure 27. APAC Human Prothrombin Complex Revenue YoY (2019-2030) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Human Prothrombin Complex Sales Quantity YoY (2019-2030) & (K Units)
Figure 29. Middle East, Africa and Latin America Human Prothrombin Complex Revenue YoY (2019-2030) & (US$ Million)
Figure 30. The Top 10 and Top 5 Players Market Share by Human Prothrombin Complex Sales Quantity in 2023
Figure 31. The Top 10 and Top 5 Players Market Share by Human Prothrombin Complex Revenue in 2023
Figure 32. Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 33. Global Human Prothrombin Complex Sales Quantity Market Share by Type (2019-2030)
Figure 34. Global Human Prothrombin Complex Revenue Market Share by Type (2019-2030)
Figure 35. Global Human Prothrombin Complex Sales Quantity Market Share by Application (2019-2030)
Figure 36. Global Human Prothrombin Complex Revenue Market Share by Application (2019-2030)
Figure 37. North America Human Prothrombin Complex Revenue Market Share by Company in 2023
Figure 38. North America Human Prothrombin Complex Sales Quantity Market Share by Company in 2023
Figure 39. North America Human Prothrombin Complex Sales Quantity Market Share by Type (2019-2030)
Figure 40. North America Human Prothrombin Complex Revenue Market Share by Type (2019-2030)
Figure 41. North America Human Prothrombin Complex Sales Quantity Market Share by Application (2019-2030)
Figure 42. North America Human Prothrombin Complex Revenue Market Share by Application (2019-2030)
Figure 43. North America Human Prothrombin Complex Revenue Share by Country (2019-2030)
Figure 44. North America Human Prothrombin Complex Sales Quantity Share by Country (2019-2030)
Figure 45. U.S. Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 46. Canada Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 47. Europe Human Prothrombin Complex Sales Quantity Market Share by Company in 2023
Figure 48. Europe Human Prothrombin Complex Revenue Market Share by Company in 2023
Figure 49. Europe Human Prothrombin Complex Sales Quantity Market Share by Type (2019-2030)
Figure 50. Europe Human Prothrombin Complex Revenue Market Share by Type (2019-2030)
Figure 51. Europe Human Prothrombin Complex Sales Quantity Market Share by Application (2019-2030)
Figure 52. Europe Human Prothrombin Complex Revenue Market Share by Application (2019-2030)
Figure 53. Europe Human Prothrombin Complex Revenue Share by Country (2019-2030)
Figure 54. Europe Human Prothrombin Complex Sales Quantity Share by Country (2019-2030)
Figure 55. Germany Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 56. France Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 57. U.K. Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 58. Italy Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 59. Russia Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 60. China Human Prothrombin Complex Sales Quantity Market Share by Company in 2023
Figure 61. China Human Prothrombin Complex Revenue Market Share by Company in 2023
Figure 62. China Human Prothrombin Complex Sales Quantity Market Share by Type (2019-2030)
Figure 63. China Human Prothrombin Complex Revenue Market Share by Type (2019-2030)
Figure 64. China Human Prothrombin Complex Sales Quantity Market Share by Application (2019-2030)
Figure 65. China Human Prothrombin Complex Revenue Market Share by Application (2019-2030)
Figure 66. APAC Human Prothrombin Complex Sales Quantity Market Share by Company in 2023
Figure 67. APAC Human Prothrombin Complex Revenue Market Share by Company in 2023
Figure 68. APAC Human Prothrombin Complex Sales Quantity Market Share by Type (2019-2030)
Figure 69. APAC Human Prothrombin Complex Revenue Market Share by Type (2019-2030)
Figure 70. APAC Human Prothrombin Complex Sales Quantity Market Share by Application (2019-2030)
Figure 71. APAC Human Prothrombin Complex Revenue Market Share by Application (2019-2030)
Figure 72. APAC Human Prothrombin Complex Revenue Share by Region (2019-2030)
Figure 73. APAC Human Prothrombin Complex Sales Quantity Share by Region (2019-2030)
Figure 74. Japan Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 75. South Korea Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 76. China Taiwan Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 77. Southeast Asia Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 78. India Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 79. Middle East, Africa and Latin America Human Prothrombin Complex Sales Quantity Market Share by Company in 2023
Figure 80. Middle East, Africa and Latin America Human Prothrombin Complex Revenue Market Share by Company in 2023
Figure 81. Middle East, Africa and Latin America Human Prothrombin Complex Sales Quantity Market Share by Type (2019-2030)
Figure 82. Middle East, Africa and Latin America Human Prothrombin Complex Revenue Market Share by Type (2019-2030)
Figure 83. Middle East, Africa and Latin America Human Prothrombin Complex Sales Quantity Market Share by Application (2019-2030)
Figure 84. Middle East, Africa and Latin America Human Prothrombin Complex Revenue Market Share by Application (2019-2030)
Figure 85. Middle East, Africa and Latin America Human Prothrombin Complex Sales Quantity Share by Country (2019-2030)
Figure 86. Middle East, Africa and Latin America Human Prothrombin Complex Revenue Share by Country (2019-2030)
Figure 87. Brazil Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 88. Mexico Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 89. Turkey Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 90. Israel Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 91. GCC Countries Human Prothrombin Complex Revenue (2019-2030) & (US$ Million)
Figure 92. Human Prothrombin Complex Value Chain
Figure 93. Human Prothrombin Complex Production Process
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Human Prothrombin Complex market?
The top companies in the global Human Prothrombin Complex market are Takeda、CSL、Grifols.
What was the global market size of Human Prothrombin Complex in 2030?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Human Prothrombin Complex market size from 2024 to 2030?
What was the global market size of Human Prothrombin Complex in 2024?
Related Reports
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Prothrombin Complex market size was US$ 2177 million in 2025 and is forecast to reach a readjusted size of US$ 4702 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 80
USD 4250.00
(Single User License)
Global Human Prothrombin Complex Market Research Report 2026
The global Human Prothrombin Complex market was valued at US$ 2177 million in 2025 and is anticipated to reach US$ 4702 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 117
USD 2900.00
(Single User License)
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Prothrombin Complex was estimated to be worth US$ 2177 million in 2025 and is projected to reach US$ 4702 million, growing at a CAGR of 11.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 100
USD 3950.00
(Single User License)
Global Human Prothrombin Complex Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Prothrombin Complex market is projected to grow from US$ 1968 million in 2024 to US$ 4251 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 146
USD 4900.00
(Single User License)
Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Human Prothrombin Complex was estimated to be worth US$ 1968 million and is forecast to reach approximately US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 139
USD 5900.00
(Single User License)
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Prothrombin Complex market size was US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 80
USD 4250.00
(Single User License)
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Prothrombin Complex was estimated to be worth US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 100
USD 3950.00
(Single User License)
Global Human Prothrombin Complex Market Research Report 2025
The global market for Human Prothrombin Complex was valued at US$ 1968 million in the year 2024 and is projected to reach a revised size of US$ 4251 million by 2031, growing at a CAGR of 11.8% during the forecast period.
Published Date: 2025-01-16
Pages: 86
USD 2900.00
(Single User License)
Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-16
Pages: 137
USD 5900.00
(Single User License)
Global Human Prothrombin Complex Market Insights, Forecast to 2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-07
Pages: 90
USD 4900.00
(Single User License)
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Prothrombin Complex market size was US$ 2177 million in 2025 and is forecast to reach a readjusted size of US$ 4702 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 80
USD 4250.00 (Single User License)Global Human Prothrombin Complex Market Research Report 2026
The global Human Prothrombin Complex market was valued at US$ 2177 million in 2025 and is anticipated to reach US$ 4702 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 117
USD 2900.00 (Single User License)Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Prothrombin Complex was estimated to be worth US$ 2177 million in 2025 and is projected to reach US$ 4702 million, growing at a CAGR of 11.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 100
USD 3950.00 (Single User License)Global Human Prothrombin Complex Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Prothrombin Complex market is projected to grow from US$ 1968 million in 2024 to US$ 4251 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 146
USD 4900.00 (Single User License)Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Human Prothrombin Complex was estimated to be worth US$ 1968 million and is forecast to reach approximately US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 139
USD 5900.00 (Single User License)Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Prothrombin Complex market size was US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 80
USD 4250.00 (Single User License)Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Prothrombin Complex was estimated to be worth US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 100
USD 3950.00 (Single User License)Global Human Prothrombin Complex Market Research Report 2025
The global market for Human Prothrombin Complex was valued at US$ 1968 million in the year 2024 and is projected to reach a revised size of US$ 4251 million by 2031, growing at a CAGR of 11.8% during the forecast period.
Published: 2025-01-16
Pages: 86
USD 2900.00 (Single User License)Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-16
Pages: 137
USD 5900.00 (Single User License)Global Human Prothrombin Complex Market Insights, Forecast to 2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-07
Pages: 90
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 5600.00
USD 8400.00
USD 11200.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now